A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients
Clinical trial NCT00261521 · COMPLETED
Trial details
- NCT number
- NCT00261521
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-02-01
- Enrollment
- 596
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.